COMP <GO>
MREO vs BMEA // FORWARD P/E MULTIPLE
Mereo BioPharma Group plc (NASDAQ) VS. Biomea Fusion Inc. (NASDAQ) • 15-METRIC TALLY: MREO 1
— BMEA 1
■ METRIC PARITY
LAST: $0.29 (+0.17%) • MKT CAP: $46.2M
forward-pe
—
LAST: $0.66 (+3.19%) • MKT CAP: $46.4M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MREO VS. BMEA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MREO | BMEA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.7 | 29.0 | +14.70 | MREO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.2M | $46.4M | -$143.8K | BMEA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MREO REV | BMEA REV | MREO GROSS % | BMEA GROSS % | MREO FCF | BMEA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $500.0K | $233.8M | — | — | -$31.0M | -$70.4M |
| FY 2024 | $132.6M | $403.4M | — | — | -$32.8M | -$120.3M |
| FY 2023 | $10.0M | $353.2M | — | — | -$21.1M | -$96.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MREO // BETA —
BMEA // BETA —